Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT05351905
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 25 years
2. Able to understand and read English
3. Experiencing chronic, non-palliative pain
Exclusion Criteria:
1. Use of nabilone, nabiximols or cannabis in the 30 days preceding study recruitment
2. Known allergy to cannabis or any cannabinoid
3. Serious ongoing medical issues (i.e., lung, liver, kidney or heart disease) that in the opinion of the Investigator would compromise the safety of the patient
4. Current uncontrolled serious mental disorders such as schizophrenia, or psychosis
5. Currently pregnant or breast-feeding (a negative urine pregnancy test must be obtained for women of child bearing potential during pretreatment evaluation)
6. Men and women planning to start a family in the next 12 weeks
7. Has declared a current alcohol or substance use disorder (excluding opioid use disorder)
8. Currently using Methadone or Buprenorphine
9. Patients who are naïve to pain treatments
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Study:
NCT05351905
Study Brief:
Protocol Section:
NCT05351905